The psychosocial impact of childhood dementia on children and their parents: a systematic review

[1]  M. Farrar,et al.  Childhood Dementia: A Collective Clinical Approach to Advance Therapeutic Development and Care. , 2022, Pediatric neurology.

[2]  R. Giugliani,et al.  Sanfilippo syndrome: consensus guidelines for clinical care , 2022, Orphanet Journal of Rare Diseases.

[3]  J. Denecke,et al.  Health-Related Quality of Life and mental health of families with children and adolescents affected by rare diseases and high disease burden: the perspective of affected children and their siblings , 2022, BMC Pediatrics.

[4]  N. Braverman,et al.  Characterization of Severity in Zellweger Spectrum Disorder by Clinical Findings: A Scoping Review, Meta-Analysis and Medical Chart Review , 2022, Cells.

[5]  I. V. van Rooij,et al.  Common needs in uncommon conditions: a qualitative study to explore the need for care in pediatric patients with rare diseases , 2022, Orphanet Journal of Rare Diseases.

[6]  C. Reilly,et al.  Parental experiences of having a child with CLN3 disease (juvenile Batten disease) and how these experiences relate to family resilience , 2022, Child: care, health and development.

[7]  G. Baynam,et al.  Research on rare diseases: ten years of progress and challenges at IRDiRC , 2022, Nature Reviews Drug Discovery.

[8]  J. E. Wraith,et al.  mucopolysaccharidosis , 2022, CABI Compendium.

[9]  B. Rosenblatt,et al.  Experience of Parents of Children with Genetically Determined Leukoencephalopathies Regarding the Adapted Health Care Services During the COVID-19 Pandemic , 2022, Journal of child neurology.

[10]  S. Chin,et al.  Prevalence of lysosomal storage disorders in Australia from 2009 to 2020 , 2021, The Lancet regional health. Western Pacific.

[11]  Anne R. Pariser,et al.  The national economic burden of rare disease in the United States in 2019 , 2021, Orphanet Journal of Rare Diseases.

[12]  K. Barlow-Stewart,et al.  Psychosocial impact of genetic testing on parents of children with developmental and epileptic encephalopathy , 2021, Developmental Medicine & Child Neurology.

[13]  E. Wirrell,et al.  DRAVET ENGAGE. Parent caregivers of children with Dravet syndrome: Perspectives, needs, and opportunities for clinical research , 2021, Epilepsy & Behavior.

[14]  C. Y. Ooi,et al.  Siblings of young people with chronic illness: Caring responsibilities and psychosocial functioning , 2021, Journal of child health care : for professionals working with children in the hospital and community.

[15]  S. Groeschel,et al.  The impact of severe rare chronic neurological disease in childhood on the quality of life of families—a study on MLD and PCH2 , 2021, Orphanet Journal of Rare Diseases.

[16]  Michael Boettcher,et al.  Being the Pillar for Children with Rare Diseases—A Systematic Review on Parental Quality of Life , 2021, International journal of environmental research and public health.

[17]  Y. Zurynski,et al.  Rare diseases research and policy in Australia: On the journey to equitable care , 2021, Journal of paediatrics and child health.

[18]  R. Śmigiel,et al.  Clinical presentation of Rett syndrome in relation to quality of life and family functioning , 2021, The Journal of international medical research.

[19]  A. Perera-Lluna,et al.  Global Collaborative Social Network (Share4Rare) to Promote Citizen Science in Rare Disease Research: Platform Development Study , 2021, JMIR formative research.

[20]  S. Calderoni,et al.  Post-Traumatic Stress Reactions in Caregivers of Children and Adolescents/Young Adults with Severe Diseases: A Systematic Review of Risk and Protective Factors , 2020, International journal of environmental research and public health.

[21]  C. Wakefield,et al.  Genetic Testing in the Pediatric Nephrology Clinic: Understanding Families' Experiences , 2020, Journal of Pediatric Genetics.

[22]  X. Estivill,et al.  Barriers and Considerations for Diagnosing Rare Diseases in Indigenous Populations , 2020, Frontiers in Pediatrics.

[23]  S. Parker,et al.  Parent Experiences of Sanfilippo Syndrome Impact and Unmet Treatment Needs: A Qualitative Assessment , 2020, Neurology and Therapy.

[24]  K. Kunzmann,et al.  Challenging behavior in mucopolysaccharidoses types I–III and day-to-day coping strategies: a cross sectional explorative study , 2020, Orphanet Journal of Rare Diseases.

[25]  S. Pal,et al.  Differential diagnosis of progressive intellectual and neurological deterioration in children , 2020, Developmental medicine and child neurology.

[26]  S. Kölker,et al.  Quantitative retrospective natural history modeling for orphan drug development , 2020, Journal of inherited metabolic disease.

[27]  A. Bye,et al.  The information needs of parents of children with early-onset epilepsy: A systematic review , 2020, Epilepsy & Behavior.

[28]  G. Lopez,et al.  The natural history of type 2 Gaucher disease in the 21st century , 2020, Neurology.

[29]  M. Tarnopolsky,et al.  Stress in Parents of Children With Genetically Determined Leukoencephalopathies: A Pilot Study , 2020, Journal of child neurology.

[30]  Kathleen R. Bogart,et al.  Social support, stress, and life satisfaction among adults with rare diseases. , 2020, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[31]  P. Lockhart,et al.  Parental health spillover effects of paediatric rare genetic conditions , 2020, Quality of Life Research.

[32]  C. Ferreira,et al.  A Scoping Review of Inborn Errors of Metabolism Causing Progressive Intellectual and Neurologic Deterioration (PIND) , 2020, Frontiers in Neurology.

[33]  C. Tifft,et al.  The natural history of Type 1 infantile GM1 gangliosidosis: A literature-based meta-analysis. , 2019, Molecular genetics and metabolism.

[34]  J. Eisengart,et al.  The nature and impact of neurobehavioral symptoms in neuronopathic Hunter syndrome , 2019, Molecular genetics and metabolism reports.

[35]  A. Spector,et al.  Psychosocial interventions for dementia in low- and middle-income countries (LMICs): a systematic review of effectiveness and implementation readiness , 2019, Aging & mental health.

[36]  Tara M Cousineau,et al.  The Role of Compassion and Mindfulness in Building Parental Resilience When Caring for Children With Chronic Conditions: A Conceptual Model , 2019, Front. Psychol..

[37]  C. Lourenço,et al.  Analysis of the caregiver burden associated with Sanfilippo syndrome type B: panel recommendations based on qualitative and quantitative data , 2019, Orphanet Journal of Rare Diseases.

[38]  M. Yates,et al.  Burnout in oncologists and associated factors: A systematic literature review and meta-analysis. , 2019, European journal of cancer care.

[39]  H. Leonard,et al.  Longitudinal effects of caregiving on parental well-being: the example of Rett syndrome, a severe neurological disorder , 2019, European Child & Adolescent Psychiatry.

[40]  M. Mahadevan,et al.  Emotional experience in parents of children with Zellweger spectrum disorders: A qualitative study , 2019, Molecular genetics and metabolism reports.

[41]  D. Palacios-Ceña,et al.  “Living an Obstacle Course”: A Qualitative Study Examining the Experiences of Caregivers of Children with Rett Syndrome , 2018, International journal of environmental research and public health.

[42]  Sian Rees,et al.  Impact of patient and public involvement on enrolment and retention in clinical trials: systematic review and meta-analysis , 2018, British Medical Journal.

[43]  Anne R. Pariser,et al.  From scientific discovery to treatments for rare diseases – the view from the National Center for Advancing Translational Sciences – Office of Rare Diseases Research , 2018, Orphanet Journal of Rare Diseases.

[44]  B. Davidson,et al.  Lysosomal storage diseases , 2018, Nature Reviews Disease Primers.

[45]  Lisa S. Rotenstein,et al.  Prevalence of Burnout Among Physicians: A Systematic Review , 2018, JAMA.

[46]  M. Burke,et al.  Caregiving Roles of Siblings of Adults With Intellectual and Developmental Disabilities: A Systematic Review , 2018, Journal of Policy and Practice in Intellectual Disabilities.

[47]  A. Vanderver,et al.  Health-Related Quality of Life for Patients With Genetically Determined Leukoencephalopathy. , 2018, Pediatric neurology.

[48]  A. Earnest,et al.  Optimism, opportunities, outcomes: the Australian Cystic Fibrosis Data Registry , 2018, Internal medicine journal.

[49]  David R. FitzPatrick,et al.  Paediatric genomics: diagnosing rare disease in children , 2018, Nature Reviews Genetics.

[50]  C. Stille,et al.  From Strangers in a Foreign Land to Active, Engaged Citizens , 2018, Pediatrics.

[51]  Zachary Munn,et al.  What kind of systematic review should I conduct? A proposed typology and guidance for systematic reviewers in the medical and health sciences , 2018, BMC Medical Research Methodology.

[52]  K. Baumstarck,et al.  Impact of caring for patients with severe and complex disabilities on health care workers’ quality of life: determinants and specificities , 2017, Developmental medicine and child neurology.

[53]  Hossam M. Hammady,et al.  Rayyan—a web and mobile app for systematic reviews , 2016, Systematic Reviews.

[54]  L. Biesecker,et al.  Family functioning mediates adaptation in caregivers of individuals with Rett syndrome. , 2016, Patient education and counseling.

[55]  P. Larkin,et al.  Parents’ experiences of living with, and caring for children, adolescents and young adults with Mucopolysaccharidosis (MPS) , 2016, Orphanet Journal of Rare Diseases.

[56]  N. Bernasconi.  Is epilepsy a curable neurodegenerative disease? , 2016, Brain : a journal of neurology.

[57]  N. Greenwood,et al.  Psychosocial interventions for people with young onset dementia and their carers: a systematic review , 2016, International Psychogeriatrics.

[58]  F. Eichler,et al.  Metachromatic Leukodystrophy , 2016, Journal of child neurology.

[59]  Hye-Seung Lee,et al.  Caretaker Quality of Life in Rett Syndrome: Disorder Features and Psychological Predictors , 2022 .

[60]  Yvonne Zurynski,et al.  Rare diseases are a 'common' problem for clinicians. , 2015, Australian family physician.

[61]  C. Chew‐Graham,et al.  PICO, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews , 2014, BMC Health Services Research.

[62]  Anthony Herbert,et al.  Components and principles of a pediatric palliative care consultation: results of a Delphi study. , 2014, Journal of palliative medicine.

[63]  H. Leonard,et al.  Twenty years of surveillance in Rett syndrome: what does this tell us? , 2014, Orphanet Journal of Rare Diseases.

[64]  S. Packman,et al.  MPS II: Adaptive Behavior of Patients and Impact on the Family System , 2014, Journal of Genetic Counseling.

[65]  D. Knol,et al.  Caregivers’ understanding of dementia predicts patients’ comfort at death: a prospective observational study , 2013, BMC Medicine.

[66]  G. Livingston,et al.  Grief reactions in dementia carers: a systematic review , 2013, International journal of geriatric psychiatry.

[67]  F. Sedel,et al.  The French Gaucher’s disease registry: clinical characteristics, complications and treatment of 562 patients , 2012, Orphanet Journal of Rare Diseases.

[68]  C. Malcolm,et al.  Challenging symptoms in children with rare life‐limiting conditions: findings from a prospective diary and interview study with families , 2012, Acta paediatrica.

[69]  Domenica Taruscio,et al.  The need for worldwide policy and action plans for rare diseases , 2012, Acta paediatrica.

[70]  M. Baker,et al.  The impact of parent advocacy groups, the Internet, and social networking on rare diseases: The IDEA League and IDEA League United Kingdom example , 2011, Epilepsia.

[71]  L. Curnow,et al.  Lessons learned from 20 years of newborn screening for cystic fibrosis , 2011, The Medical journal of Australia.

[72]  P. Casey,et al.  Increasing Prevalence of Medically Complex Children in US Hospitals , 2010, Pediatrics.

[73]  I. Kuratsubo,et al.  Parents of childhood X-linked adrenoleukodystrophy: High risk for depression and neurosis , 2008, Brain and Development.

[74]  Helvi Kyngäs,et al.  The qualitative content analysis process. , 2008, Journal of advanced nursing.

[75]  P. Magnus,et al.  Incidence rates of progressive childhood encephalopathy in Oslo, Norway: a population based study , 2007, BMC pediatrics.

[76]  S. Heriot,et al.  Vicarious Futurity in Autism and Childhood Dementia , 2007, Journal of autism and developmental disorders.

[77]  C. Hatton,et al.  Burnout amongst direct care workers in services for adults with intellectual disabilities : a systematic review of research findings and initial normative data. , 2007 .

[78]  C. Mignot,et al.  Type 2 Gaucher disease: 15 new cases and review of the literature , 2006, Brain and Development.

[79]  A. Hamosh,et al.  Natural history of nonketotic hyperglycinemia in 65 patients , 2004, Neurology.

[80]  Robert C. Lee,et al.  STANDARD QUALITY ASSESSMENT CRITERIA FOR EVALUATING PRIMARY RESEARCH PAPERS FROM A VARIETY OF FIELDS , 2004 .

[81]  R. Ouvrier,et al.  The Australian Childhood Dementia Study , 2002, European Child & Adolescent Psychiatry.

[82]  L. Varvogli,et al.  Personality profiles of mothers of children with mitochondrial disorders , 1999, Journal of Inherited Metabolic Disease.

[83]  B Hagberg,et al.  The epidemiology of progressive encephalopathies in childhood. I. Live birth prevalence in west Sweden. , 1992, Neuropediatrics.

[84]  Leo Goldman,et al.  Qualitative Assessment , 1990 .

[85]  N. Krawiecki,et al.  Neurodegenerative diseases of infancy and childhood , 1983, Annals of neurology.

[86]  Z. Aszalós,et al.  [Epilepsy in children]. , 1962, Orvosi hetilap.

[87]  L. Haverman,et al.  Psychosocial Functioning in Parents of MPS III Patients. , 2019, JIMD reports.

[88]  K. Brown,et al.  Biopsychosocial Predictors of Quality of Life Outcomes in Pediatric Congenital Heart Disease , 2017, Pediatric Cardiology.

[89]  P. Mistry,et al.  Long-term hematological, visceral, and growth outcomes in children with Gaucher disease type 3 treated with imiglucerase in the International Collaborative Gaucher Group Gaucher Registry. , 2017, Molecular genetics and metabolism.

[90]  L. Ward,et al.  The Parent Experience of Caring for a Child with Mitochondrial Disease. , 2016, Journal of pediatric nursing.

[91]  K. Mahtani,et al.  PROSPERO International prospective register of systematic reviews Mindfulness: an overview of systematic reviews Citation Review question(s) Searches Types of study to be included Participants/ population , 2016 .

[92]  A. Galanopoulou,et al.  Epilepsy and epileptic syndrome. , 2012, Advances in experimental medicine and biology.

[93]  D. Moher,et al.  PRISMA statement. , 2011, Epidemiology.

[94]  Y. Zurynski,et al.  Call for a national plan for rare diseases , 2010, Journal of paediatrics and child health.

[95]  J. Popay,et al.  Guidance on the conduct of narrative synthesis in sytematic reviews , 2006 .

[96]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..